The World Health Organization provides data on the percentage of bacteriologically confirmed pulmonary tuberculosis patients with a susceptibility test result for rifampicin. This dataset likely contains aggregated metrics for monitoring TB drug resistance patterns. Its specific temporal and geographic coverage is not detailed in the available metadata.
Use Cases
- Monitoring trends in rifampicin susceptibility testing coverage among TB patients (inferred from domain, verify after download)
- Assessing laboratory capacity for drug resistance testing in different regions (inferred from domain, verify after download)
- Informing policy on TB diagnosis and treatment protocols (inferred from domain, verify after download)
Strengths
- Published on the World Health Organization's Global Health Observatory platform.
- Organization is the World Health Organization (WHO).
Limitations
- Metadata is minimal; actual content requires verification after download.
- Column-level documentation is absent; field semantics must be inferred after download.
- Last update date is unknown; freshness unverified.
Provenance
- Source
- World Health Organization (WHO)
- Collection Method
- null
- Time Range
- null
- Freshness
- null
- Geography
- null